Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
Characteristics of Clinical Studies Used for US Food and Drug Administration Supplemental Indication Approvals of Drugs and Biologics, 2017 to 2019.
Journal: JAMA network open
Published: June 10, 2021
Use of intravenous magnesium sulfate among patients with acute myocardial infarction in China from 2001 to 2015: China PEACE-Retrospective AMI Study.
Journal: BMJ open
Published: March 30, 2020
Identification of Racial Inequities in Access to Specialized Inpatient Heart Failure Care at an Academic Medical Center.
Journal: Circulation. Heart failure
Published: October 30, 2019
Association of Racial and Socioeconomic Disparities With Outcomes Among Patients Hospitalized With Acute Myocardial Infarction, Heart Failure, and Pneumonia: An Analysis of Within- and Between-Hospital Variation.
Journal: JAMA network open
Published: January 16, 2019
Factors Associated With Postmarketing Research for Approved Indications for Novel Medicines Approved by Both the FDA and EMA Between 2005 and 2010: A Multivariable Analysis.
Journal: Clinical pharmacology and therapeutics
Published: December 12, 2017
New and incremental FDA black box warnings from 2008 to 2015.
Journal: Expert opinion on drug safety
Published: December 08, 2017
Characteristics of Novel Therapeutics and Postmarket Safety Events-Reply.
Journal: JAMA
Published: October 05, 2017
Ischaemic heart disease in China: the time to address rising mortality rates.
Journal: European heart journal. Quality of care & clinical outcomes
Published: September 21, 2017
Regulatory Review of New Therapeutic Agents.
Journal: The New England journal of medicine
Published: June 29, 2017
Quality of Care in Chinese Hospitals: Processes and Outcomes After ST-segment Elevation Myocardial Infarction.
Journal: Journal of the American Heart Association
Published: June 25, 2017
Last Updated: 09/26/2026